0001209191-16-113722.txt : 20160408
0001209191-16-113722.hdr.sgml : 20160408
20160408151520
ACCESSION NUMBER: 0001209191-16-113722
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160406
FILED AS OF DATE: 20160408
DATE AS OF CHANGE: 20160408
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161562527
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-04-06
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-04-06
4
M
0
5130
35.35
A
270414
D
Common Stock
2016-04-06
4
S
0
900
86.56
D
269514
D
Common Stock
2016-04-06
4
S
0
500
88.19
D
269014
D
Common Stock
2016-04-06
4
S
0
800
89.53
D
268214
D
Common Stock
2016-04-06
4
S
0
2230
90.60
D
265984
D
Common Stock
2016-04-06
4
S
0
700
91.12
D
265284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock Held In Trust
Stock Option (Right to Buy)
35.35
2016-04-06
4
M
0
5130
0.00
D
2016-07-19
Common Stock
5130
66700
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $86.56 (range $86.30 to $86.81).
Open market sales reported on this line occurred at a weighted average price of $88.19 (range $87.69 to $88.48).
Open market sales reported on this line occurred at a weighted average price of $89.53 (range $88.95 to $89.88).
Open market sales reported on this line occurred at a weighted average price of $90.60 (range $89.95 to $90.92).
Open market sales reported on this line occurred at a weighted average price of $91.12 (range $90.99 to $91.41).
Fully vested.
Omar White, Attorney-In-Fact
2016-04-08